| http://www.w3.org/ns/prov#value | - apeutic agents and therapies that can be used to increase low HDL-C levels and consequently to prevent CVD, T2D, MBO, obesity and other conditions related to low HDL-C before they manifest clinically; to prevent complications, to treat clinical symptoms and/or to retard the progression of said diseases and conditions.
|
